Literature DB >> 15574852

Clinical implications of ST-segment non-resolution after thrombolysis for myocardial infarction.

L Bhatia1, G J Clesham, D R Turner.   

Abstract

Failed reperfusion after thrombolytic therapy for acute myocardial infarction is common and signifies a poor prognosis. We investigated the clinical consequences of non-resolution of the ST segment after thrombolytic therapy for acute ST-elevation myocardial infarction, in 85 consecutive patients admitted to a coronary care unit lacking rapid access to angioplasty. Failed thrombolysis was defined as <50% ST-segment resolution 180 minutes after the start of thrombolytic treatment. Outcomes were measured in terms of in-hospital adverse events, length of hospital stay, and mortality at 6 weeks and 1 year. Thrombolysis was successful, in terms of ST-segment resolution, in 45 patients (53%). After adjustment for other factors, ST resolution was the only independent predictor of an uncomplicated recovery in hospital (odds ratio 6.8, 95% confidence interval 2.3 to 19.9; P<0.001). At 6 weeks and 1 year, overall mortality was lower in the ST resolution group, though these differences became non-significant on multivariate analysis. In patients who survived to hospital discharge, median length of stay was greater in successfully thrombolysed patients (9 days versus 8 days) despite their lower rate of complications. ST-segment resolution is a useful marker of successful thrombolysis and relates to clinical outcome. If assessed routinely it might assist, along with other clinical markers, in the identification of low-risk patients who can be discharged early.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574852      PMCID: PMC1079667          DOI: 10.1177/014107680409701203

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   18.000


  30 in total

1.  Hospital bed utilisation in the NHS, Kaiser Permanente, and the US Medicare programme: analysis of routine data.

Authors:  Chris Ham; Nick York; Steve Sutch; Rob Shaw
Journal:  BMJ       Date:  2003-11-29

2.  Does ageism affect the management of ischaemic heart disease?

Authors:  Matthew Bond; Ann Bowling; Dorothy McKee; Marian Kennelly; Adrian P Banning; Nigel Dudley; Andrew Elder; Anthony Martin
Journal:  J Health Serv Res Policy       Date:  2003-01

3.  A randomized controlled trial of hospital discharge three days after myocardial infarction in the era of reperfusion.

Authors:  E J Topol; K Burek; W W O'Neill; D G Kewman; N H Kander; M J Shea; M A Schork; J Kirscht; J E Juni; B Pitt
Journal:  N Engl J Med       Date:  1988-04-28       Impact factor: 91.245

4.  Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of Early Intervention in Myocardial Infarction.

Authors:  G I Barbash; A Roth; H Hod; H I Miller; S Rath; Y Har-Zahav; M Modan; U Seligsohn; A Battler; E Kaplinsky
Journal:  Br Heart J       Date:  1990-10

5.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

6.  Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction.

Authors:  R Schröder; R Dissmann; T Brüggemann; K Wegscheider; T Linderer; U Tebbe; K L Neuhaus
Journal:  J Am Coll Cardiol       Date:  1994-08       Impact factor: 24.094

7.  Does PTCA in acute myocardial infarction affect mortality and reinfarction rates? A quantitative overview (meta-analysis) of the randomized clinical trials.

Authors:  K B Michels; S Yusuf
Journal:  Circulation       Date:  1995-01-15       Impact factor: 29.690

8.  A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial.

Authors:  Andrew G C Sutton; Philip G Campbell; Richard Graham; Dallas J A Price; Janine C Gray; Ever D Grech; James A Hall; Alun A Harcombe; Robert A Wright; Roger H Smith; Jerry J Murphy; Ananthaiah Shyam-Sundar; Michael J Stewart; Adrian Davies; Nicholas J Linker; Mark A de Belder
Journal:  J Am Coll Cardiol       Date:  2004-07-21       Impact factor: 24.094

9.  Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1988-08-13       Impact factor: 79.321

Review 10.  Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

View more
  1 in total

1.  Successful medical management of a left ventricular thrombus and aneurysm following failed thrombolysis in myocardial infarction.

Authors:  Adebayo T Oyedeji; Christopher Lee; Olukolade O Owojori; Olabanji J Ajegbomogun; Adeseye A Akintunde
Journal:  Clin Med Insights Cardiol       Date:  2013-02-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.